Commentary on the Epidemiology of Inflammatory Bowel Disease in Compounding Prevalence Nations: Toward Sustaining Healthcare Delivery

Inflammatory bowel disease (IBD), namely Crohn ’s disease and ulcerative colitis, affects millions of individuals worldwide.1 IBD is characterized geographically by epidemiologic stages: Stage 1 (emergence) includes developing regions with low incidence and prevalence; stage 2 (acceleration in incidence) includes newly industrialized regions i n Asia and Latin America with rapidly rising incidence but low prevalence; and stage 3 (compounding prevalence) includes early industrialized regions in North America, Europe, and Oceania with steadily climbing prevalence due to the cumulative effect of incidence greatly exceeding mortality over tim e.

Source: Gastroenterology - February 17, 2024 Category: Gastroenterology Authors: Michelle Herauf, Stephanie Coward, Juan-Nicol ás Peña-Sánchez, Charles N. Bernstein, Eric I. Benchimol, Gilaad G. Kaplan, Canadian Gastro-Intestinal Epidemiology Consortium Tags: Commentary Source Type: research